lower back pain after semaglutide and Semaglutide: What Research Shows Stopping Semaglutide: How to Keep

The OFAs October suit delayed enforcement for a few months while the FDA reconsidered its decision, but on March 5 th , the court upheld the FDAs determination that the tirzepatide shortage had ended.[xi] While it is possible that the OFAs suit challenging the February Declaratory Order could end differently, it is likely to have a similar outcome as the OFAs challenge of tirzepatides removal from the shortage list

Pregnancy and breastfeeding are off limits

Dive Brief: As employers grapple with worker demand for GLP-1 drugs for weight loss, 1 in 5 employers recommend employees use their FSA, HSA or integrated HRA to acquire them, according to new research from the International Foundation of Employee Benefit Plans

Two registered trials exist: a Phase 1 safety and pharmacokinetics study (NCT02637284) with no posted results, and a Phase 2 hamstring-strain trial (NCT07437547) still recruiting

Our findings demonstrated that GSH catabolism by GGTs supports cancer cell growth and survival

Hamidi et al., 2023) (see Table 2)